| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/26/2004 | US20040038407 From plants having decreased content of anthocyanins; enzyme inhibitors |
| 02/26/2004 | US20040038406 Nanoparticle delivery systems and methods of use thereof |
| 02/26/2004 | US20040038405 Vectors and viral vectors, and packaging cell lines for propagating same |
| 02/26/2004 | US20040038404 Comprises deletion in adenovirus-2 early region 1A gene; for expression of a protein effective in regulating the cell cycle (such as p53, mitosin, or thymidine kinase suicide genes); tumor suppressor genes/proteins |
| 02/26/2004 | US20040038403 Replication-defective; does not rely on use of tumor specific promoters |
| 02/26/2004 | US20040038402 Gene therapy; for production of transgenic animal models |
| 02/26/2004 | US20040038401 For inserting deleterious sequences |
| 02/26/2004 | US20040038400 Methods for regulating gene expression using light |
| 02/26/2004 | US20040038399 For preventing gene transcription/expression; for inducing nuclease stability, hybridization to complementary RNA sequences, permeability to oligonucleotides into cells, RNase cleavage, and blocking ribosome translocation |
| 02/26/2004 | US20040038394 Expression vector using for animal cell |
| 02/26/2004 | US20040038393 Comprises alkaline lysis, concentration by precipitation with isopropanol, pre-purification/conditioning with ammonium sulphate, then adding buffer; solid phase synthesis; gene therapy; vaccines |
| 02/26/2004 | US20040038392 Expression vector enabling screening of cells with high expression of recombinant protein, transformant with high expression of recombinant protein and utilization thereof |
| 02/26/2004 | US20040038382 Comprises genes encoding toluene-degrading enzymes having homology to Escherichia coli pyruvate formate lyase; waste treatment; pollution control |
| 02/26/2004 | US20040038381 Comprises genetically engineered strains of Pichia; mannosidases; glycoproteins; kits |
| 02/26/2004 | US20040038380 Bacterial strain of escherichia coli BKIIM B-3996 as the producer of L-threonine |
| 02/26/2004 | US20040038379 Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom |
| 02/26/2004 | US20040038375 Method for screening highly active proteases and inhibitors |
| 02/26/2004 | US20040038374 Method for accessing microbial diversity |
| 02/26/2004 | US20040038371 Aminopeptidase |
| 02/26/2004 | US20040038370 Claudin polypeptides |
| 02/26/2004 | US20040038367 Which cleaves the second beta-glucoside linkage of xyloglucans; isolated from Geotrichum species |
| 02/26/2004 | US20040038366 Improved heat resistance; genetic engineering |
| 02/26/2004 | US20040038365 Fusion proteins; for treatment/prevention of cancer, central nervous system disorders, obesity, chronic obstructive pulmonary disease, diabetes, and cardiovascular disorders; drug screening; kits |
| 02/26/2004 | US20040038364 Such as snake venom proteases; anticoagulants |
| 02/26/2004 | US20040038363 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038362 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038361 Novel protein kinase (NPK-110) |
| 02/26/2004 | US20040038359 Gene 763 of phytopathogenic fungus magnaporthe grisea and use thereof for identifying fungicidal compounds |
| 02/26/2004 | US20040038356 Method and kit for discontinuous density gradient centrifugation to separate a minimum of two substances in a sample; method and kit use is made of colloidal density media and low-density solutions |
| 02/26/2004 | US20040038353 Production of a taxanes by cloning a DNA sequence comprising a taxane synthesis pathway, making a DNA construct where the DNA sequence is under control of regulatory elements, introducing said DNA construct into a host cell, recovering the taxane |
| 02/26/2004 | US20040038352 Method for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family |
| 02/26/2004 | US20040038349 Heteromultimeric TNF ligand family members |
| 02/26/2004 | US20040038346 Vectors, host cells, and recombinant methods for making and using the novel molecules |
| 02/26/2004 | US20040038345 Discovery, identification and characterization of novel human polynucleotides that encode membrane associated proteins and receptors |
| 02/26/2004 | US20040038341 Chimeric human-type vascular endothelial cell growth factor |
| 02/26/2004 | US20040038340 Used in the processing of fermented foods by imparting an improved texture and flavor, and/or a higher content in aroma compounds; mutant has a mutation impairing the regulation of a carbon catabolite repression (CCR) mechanism |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038337 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038336 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 02/26/2004 | US20040038335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038328 Assay for melanogenesis |
| 02/26/2004 | US20040038325 Adhesion molecules |
| 02/26/2004 | US20040038317 Identifying functional fragment pairs/activation/binding sites in protein for screening and monitoring therapeutic and imaging reagents in vivo; for detection and treatment of cancer, inflammation, atherosclerosis and infection |
| 02/26/2004 | US20040038314 Immunoglobulin for diagnosis and treatment of oligospermia |
| 02/26/2004 | US20040038308 Hybrid antibodies |
| 02/26/2004 | US20040038303 Comprises use of small particle with appropriate hydrophilic-lipophilic-balance value to deliver anticarcinogenic agents to cells and/or tissues; drug screening |
| 02/26/2004 | US20040038300 Method for producing and identifying appropriate effectors of target molecules using substance libraries |
| 02/26/2004 | US20040038298 Protein fragment complementation assays for the detection of biological or drug interactions |
| 02/26/2004 | US20040038297 Masp-2,a complement-fixing enzyme, and uses for it |
| 02/26/2004 | US20040038293 Antibodies to human cd154 |
| 02/26/2004 | US20040038292 Comprises nucleotide sequences which code wound healing proteins for treatment and prevention of scarring, fibrosis, restenosis post angioplasty, psoriasis, benign prostatic hyperplasia, glaucoma and nervous suystem disorders |
| 02/26/2004 | US20040038291 Comprises immunoglobulin polypeptide library for diagnosis, prevention, suppression and/or treatment of inflammatory, cancer, viral, autoimmune and arthritic diseases |
| 02/26/2004 | US20040038288 Human protein C Polypeptide |
| 02/26/2004 | US20040038287 Nucleic acid encoding a wheat brittle-1 homolog |
| 02/26/2004 | US20040038285 Comprises polypeptide which possess hematopoietic, tissue generative/regeneration, activin/inhibin, chemotactic, hemostatic and thrombolytic activity for prevention and treatment autoimmune, viral and tumor disorders |
| 02/26/2004 | US20040038284 Using replication error phenotype (RER) to classify and prognose tumor disorders; immunoassay |
| 02/26/2004 | US20040038281 Isolated ductal fluid sample |
| 02/26/2004 | US20040038279 Comprises ubiquitin conjugating enzyme for diagnosis, prevention and treatment of cell proliferative, immunological, neurological, and reproductive disorders |
| 02/26/2004 | US20040038278 Methods and compositions relating to gene silencing |
| 02/26/2004 | US20040038275 Human frezzled-like protein |
| 02/26/2004 | US20040038274 Gapped 2' modified oligonucleotides |
| 02/26/2004 | US20040038271 Novel C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/26/2004 | US20040038269 Improving isolation and extraction of nucleic acids from saliva and preservation of nucleotide sequences at room temperature for extended periods of time |
| 02/26/2004 | US20040038265 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 02/26/2004 | US20040038263 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 02/26/2004 | US20040038259 Method of producing a temporally spaced subtracted (TSS) cDNA library and uses thereof |
| 02/26/2004 | US20040038257 Therapeutic peptidase for diagnosis, treatment and prevention of cancer and nervous system disorders |
| 02/26/2004 | US20040038255 Silver-gold shelled composite oligonucleotide conjugate for detecting target nucleic acids, peptides and proteins; colorimetric based DNA detection |
| 02/26/2004 | US20040038253 Method of synthesizing polynucleotide |
| 02/26/2004 | US20040038250 Isolating, purifying and cloning multicistronic nucleotide sequences coding polypeptides associated with biosynthesis and expression of thienamycin; rational drug design and screening |
| 02/26/2004 | US20040038249 Inducible expression systems employing PPAR transcriptional activators |
| 02/26/2004 | US20040038248 Novel polypeptide-human heterogeneous nuclear ribonucleoprotein 32.01 and the polynucleotide encoding said polypeptide |
| 02/26/2004 | US20040038247 Expression vector comprised of regulatory sequences for lymphocyte specific expression of heterologous polypeptides |
| 02/26/2004 | US20040038244 Comprises expression vector capable of chromosomal insertion and transcription of telomerase for generating transgenic somatic cells and screening and/or identifying antitumor and anticarcinogenic agents |
| 02/26/2004 | US20040038243 P53-dependent apoptosis-associated protein and method of screening apoptosis controlling agent |
| 02/26/2004 | US20040038238 Comprises chimeric membrane proteins for diagnosis, treatment and prevention of inflammation, cancer, metabolic, gastrointestinal and autoimmune disorders |
| 02/26/2004 | US20040038236 Mutation associated with epilepsy |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038233 An oligonucleotide chip including a species identification probe containing species specific DNA sequence of mycobacterial rpoB gene, a detection probe containing modified codon of rpoB gene, a contrast group probe, a marker |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038228 Microphysiometer |
| 02/26/2004 | US20040038227 Using microcalorimetric apparatus to analyze interaction between multiple chemical entities/drugs and trangenic gene product expressed in viable cells |
| 02/26/2004 | US20040038226 Transgenic animal model by mineralocorticoid receptor antisense expression |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040038218 7SK RNA regulated transcription |
| 02/26/2004 | US20040038217 Molecular constructs and methods of use for detection of biochemical reactions |
| 02/26/2004 | US20040038215 Oligonucleotide tagged nucleoside triphosphates (OTNTPs) for genetic analysis |
| 02/26/2004 | US20040038212 Novel armadillo repeat-containing protein alex1 |
| 02/26/2004 | US20040038210 Comprises nucleotide sequences coding extracellular protein for diagnosis, prevention and treatment of tumors, blood, viral and immunological diseases |
| 02/26/2004 | US20040038209 Comprises nucleotide sequences coding beta -carotene dioxygenase which cleaves beta carotene and produces vitamin a aldehyde; improving nutritional value of plants, microorganisms and animal feeds |
| 02/26/2004 | US20040038205 Modified adenoviral fiber and uses |
| 02/26/2004 | US20040038204 Replacing worn wear strip associated with viral and nonviral gene delivery systems; gene therapy |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040038200 Using monclonal antibodies to differentiate between pathogenic aggregated protein and nonpathogenic, nonaggregated protein molecules; immunoassay |
| 02/26/2004 | US20040037874 Delivery of nucleic acid-like compounds |
| 02/26/2004 | US20040037847 Assays for compounds that modulate rhadino virus lana action in trans on a unit of rhadino virus dna to mediate efficient episome persistence |
| 02/26/2004 | US20040037843 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 02/26/2004 | US20040037841 Nucleic acid sequences that are expressed in chondrocytes from fetal, normal, mild osteoarthritic, moderate osteoarthritic, marked and osteoarthritic |
| 02/26/2004 | US20040037838 Polypeptide with the amino acid sequence of the C-terminal part of the circumsporozoite protein of a plasmodium in which cysteine residues are oxidized along with carriers, adjuvants and biodegradable microcapsules |
| 02/26/2004 | US20040037837 For stimulating CD8 T-cell response; tuberculosis vaccines; antigen presenting cells |